TriSalus Life Sciences (TLSI) Retained Earnings (2020 - 2026)

TriSalus Life Sciences' Retained Earnings history runs 7 years deep, the most recent figure standing at -$329.0 million for Q1 2026.

• On a quarterly basis, Retained Earnings fell 13.5% year-over-year to -$329.0 million in Q1 2026; TTM through Mar 2026 was -$329.0 million, a 13.5% decrease from a year earlier, with the FY2025 full-year figure at -$330.6 million, down 18.26% from the prior year.
• Retained Earnings was little changed at -$329.0 million in Q1 2026 per TLSI's latest filing, from -$330.6 million in the prior quarter.
• Across five years, Retained Earnings topped out at $294.2 million in Q3 2025 and bottomed at -$330.6 million in Q4 2025.
• The 5-year median for Retained Earnings is -$186.4 million (2022), against an average of -$107.2 million.
• Across the five-year window, Retained Earnings jumped 1998.41% in 2023 and slumped 1658.71% in 2024, its largest moves.
• Year by year, Retained Earnings stood at -$186.4 million in 2022, then plunged by 33.88% to -$249.5 million in 2023, then dropped by 12.04% to -$279.5 million in 2024, then retreated by 18.26% to -$330.6 million in 2025, then grew by 0.47% to -$329.0 million in 2026.
• Per Business Quant, the three latest TLSI Retained Earnings figures stand at -$329.0 million (Q1 2026), -$330.6 million (Q4 2025), and $294.2 million (Q3 2025).